150 related articles for article (PubMed ID: 35117293)
1. Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis.
Li J; Li Y; Jin M; Huang L; Wang X
Transl Cancer Res; 2020 Nov; 9(11):6841-6856. PubMed ID: 35117293
[TBL] [Abstract][Full Text] [Related]
2. Identification of crucial genes associated with lung adenocarcinoma by bioinformatic analysis.
Dai JJ; Zhou WB; Wang B
Medicine (Baltimore); 2020 Oct; 99(44):e23052. PubMed ID: 33126397
[TBL] [Abstract][Full Text] [Related]
3. Identification of KIF4A and its effect on the progression of lung adenocarcinoma based on the bioinformatics analysis.
Song Y; Tang W; Li H
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33398330
[TBL] [Abstract][Full Text] [Related]
4. Identification key genes, key miRNAs and key transcription factors of lung adenocarcinoma.
Li J; Li Z; Zhao S; Song Y; Si L; Wang X
J Thorac Dis; 2020 May; 12(5):1917-1933. PubMed ID: 32642095
[TBL] [Abstract][Full Text] [Related]
5. An integrated analysis of prognostic and immune infiltrates for hub genes as potential survival indicators in patients with lung adenocarcinoma.
Xu Z; Wang S; Ren Z; Gao X; Xu L; Zhang S; Ren B
World J Surg Oncol; 2022 Mar; 20(1):99. PubMed ID: 35354488
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
[No Abstract] [Full Text] [Related]
7. Elevated TOP2A and UBE2C expressions correlate with poor prognosis in patients with surgically resected lung adenocarcinoma: a study based on immunohistochemical analysis and bioinformatics.
Guo W; Sun S; Guo L; Song P; Xue X; Zhang H; Zhang G; Wang Z; Qiu B; Tan F; Xue Q; Gao Y; Gao S; He J
J Cancer Res Clin Oncol; 2020 Apr; 146(4):821-841. PubMed ID: 32103339
[TBL] [Abstract][Full Text] [Related]
8. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
9. Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database.
Shen Y; Tang X; Zhou X; Yi Y; Qiu Y; Xu J; Tian X
J Oncol; 2022; 2022():4435092. PubMed ID: 36600965
[TBL] [Abstract][Full Text] [Related]
10. Weighted gene co-expression network analysis of hub genes in lung adenocarcinoma.
Luo X; Feng L; Xu W; Bai X; Wu M
Evol Bioinform Online; 2021; 17():11769343211009898. PubMed ID: 33911849
[TBL] [Abstract][Full Text] [Related]
11. Identifying and Validating Potential Biomarkers of Early Stage Lung Adenocarcinoma Diagnosis and Prognosis.
Chen Y; Jin L; Jiang Z; Liu S; Feng W
Front Oncol; 2021; 11():644426. PubMed ID: 33937050
[TBL] [Abstract][Full Text] [Related]
12. Identification of key genes and biological pathways in lung adenocarcinoma by integrated bioinformatics analysis.
Zhang L; Liu Y; Zhuang JG; Guo J; Li YT; Dong Y; Song G
World J Clin Cases; 2023 Aug; 11(23):5504-5518. PubMed ID: 37637684
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genes associated with prognosis of lung adenocarcinoma based on GEO and TCGA databases.
Yu Y; Tian X
Medicine (Baltimore); 2020 May; 99(19):e20183. PubMed ID: 32384511
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma.
Guo T; Ma H; Zhou Y
PeerJ; 2019; 7():e7313. PubMed ID: 31333911
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
Li J; Liu X; Cui Z; Han G
Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
[TBL] [Abstract][Full Text] [Related]
16. Screening and Validation of Significant Genes with Poor Prognosis in Pathologic Stage-I Lung Adenocarcinoma.
Deng Y; Chen X; Huang C; Song J; Feng S; Chen X; Zhou R
J Oncol; 2022; 2022():3794021. PubMed ID: 35444699
[TBL] [Abstract][Full Text] [Related]
17. Promising novel biomarkers and candidate small-molecule drugs for lung adenocarcinoma: Evidence from bioinformatics analysis of high-throughput data.
Li C; Wan Y; Deng W; Fei F; Wang L; Qi F; Zheng Z
Open Med (Wars); 2022; 17(1):96-112. PubMed ID: 35028418
[TBL] [Abstract][Full Text] [Related]
18. Microarray analysis of the expression profile of immune-related gene in rapid recurrence early-stage lung adenocarcinoma.
Liu J; Yang X; Zhang L; Yang B; Rao W; Li M; Dai N; Yang Y; Qian C; Zhang L; Xiao H; Wang D
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2299-2310. PubMed ID: 32556504
[TBL] [Abstract][Full Text] [Related]
19. High Expression of
Deng H; Huang Y; Wang L; Chen M
Biomed Res Int; 2020; 2020():2071593. PubMed ID: 33134373
[TBL] [Abstract][Full Text] [Related]
20. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]